國立虎尾科技大學 |

Prehypertension and Cardiometabolic Syndrome

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Prehypertension and Cardiometabolic Syndrome/ edited by Reuven Zimlichman, Stevo Julius, Giuseppe Mancia.
其他作者:	Zimlichman, Reuven.
面頁冊數:	XII, 689 p. 111 illus., 72 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cardiology. -
電子資源:	https://doi.org/10.1007/978-3-319-75310-2
ISBN:	9783319753102

Prehypertension and Cardiometabolic Syndrome
Prehypertension and Cardiometabolic Syndrome[electronic resource] /edited by Reuven Zimlichman, Stevo Julius, Giuseppe Mancia. - 1st ed. 2019. - XII, 689 p. 111 illus., 72 illus. in color.online resource. - Updates in Hypertension and Cardiovascular Protection,2366-4606. - Updates in Hypertension and Cardiovascular Protection,.

I Epidemiology and Statistics -- 1 Epidemiology, statistics and health burden -- 2 PreHypertension, the risk of Hypertension and events -- 3 Parental history of hypertension as the determinant of cardiovascular function -- 4 High normal blood pressure in children and adolescents -- II Pathophysiology of prehypertension.- Part 1 Alteration of Cardiovascular control systems -- 5 Tachycardia in PreHypertension -- 6 Endothelial dysfunction in early phases of hypertension -- 7 Prehypertension and the Renin angiotensin aldosterone system -- 8 The role of the brain in neurogenic prehypertension -- 9 The blood pressure seeking property of the brain -- Part 2 Organ damage in Prehypertension -- 10 Microvascular structural alternations and tissue perfusion in hypertension and diabetes.-11 The heart in prehypertension -- 12 The role of the kidney in PreHypertension -- 13 Obesity, Hypertension and Chronic Kidney Disease: A Forty Year Retrospective -- 14 Pre-CKD? Early markers of renal dysfunction in patients with Prehypertension -- 15 Arterial stiffness in early phases of Prehypertension -- 16 The role of perivascular fat in raising blood pressure in obesity and diabetes -- 17 The Brain -- 18 Diurnal and pulsatile hemodynamics in individuals with PreHypertension -- 19 Systolic hypertension in youth -- 20 Prehypertension and ethnicity: Haemodynamic mechanisms in young adults -- 21 Hemodynamics (systemic and renal) in prehypertension -- 22 Central blood pressure and Prehypertension -- Section 3: Risk assessment in PreHypertension -- 23 Blood pressure measurement, white coat and masked hypertension.-24 Vascular functional and structural risk assessment in prehypertension -- 25 Blood pressure variability -- 26 Morning Surge of Blood Pressure -- 27 Role of ambulatory Blood Pressure Monitoring in Prehypertension -- 28 Home blood pressure, prehypertension and hypertension -- 29 Blood pressure and atherosclerosis- subclinical arteriosclerosis as an early sign of organ damage -- 30 Response to stress, effort and cold pressor test as predictors of Prehypertension -- 31 Physical Activity and Exercise Training as Important Modifiers of Vascular Health -- 32 Prehypertension and associated metabolic risk factors -- IV End organ damage in PreHypertension -- 33 Early cardiovascular dysfunction in Prehypertension -- 34 Effect of blood pressure lowering in hypertensive rats -- V Clinical studies in PreHypertension -- 35 Review of "old and new studies" in the treatment of PreHypertension -- 36 The CHINON study- argument for early treatment of PreHypertension. Effect of age on progression of hypertension -- 37 The PREVER study -- 38 The TROPHY study -- VI Management of PreHypertension -- 39 Non-pharmacologic approaches for the management of prehypertension -- 40 Antihypertensive drugs and vascular health -- 41 Prehypertension: a case in favor of early use of diuretics -- 42 Treatment of High normal blood pressure in the guidelines -- VII Tentative additional chapters -- 43 History of prehypertension: a saga of misunderstanding and neglect -- 44 Management of Prehypertension and hypertension in women of reproductive age.

This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines. While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions – especially when multiple – are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation. In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases.

ISBN: 9783319753102

Standard No.: 10.1007/978-3-319-75310-2doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

Prehypertension and Cardiometabolic Syndrome
LDR:05962nam a22003975i 4500 001 1013772
003 DE-He213
005 20200702161500.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783319753102 $9 978-3-319-75310-2
024 7 $a 10.1007/978-3-319-75310-2 $2 doi
035 $a 978-3-319-75310-2
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
245 1 0 $a Prehypertension and Cardiometabolic Syndrome $h [electronic resource] / $c edited by Reuven Zimlichman, Stevo Julius, Giuseppe Mancia.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XII, 689 p. 111 illus., 72 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Updates in Hypertension and Cardiovascular Protection, $x 2366-4606
505 0 $a I Epidemiology and Statistics -- 1 Epidemiology, statistics and health burden -- 2 PreHypertension, the risk of Hypertension and events -- 3 Parental history of hypertension as the determinant of cardiovascular function -- 4 High normal blood pressure in children and adolescents -- II Pathophysiology of prehypertension.- Part 1 Alteration of Cardiovascular control systems -- 5 Tachycardia in PreHypertension -- 6 Endothelial dysfunction in early phases of hypertension -- 7 Prehypertension and the Renin angiotensin aldosterone system -- 8 The role of the brain in neurogenic prehypertension -- 9 The blood pressure seeking property of the brain -- Part 2 Organ damage in Prehypertension -- 10 Microvascular structural alternations and tissue perfusion in hypertension and diabetes.-11 The heart in prehypertension -- 12 The role of the kidney in PreHypertension -- 13 Obesity, Hypertension and Chronic Kidney Disease: A Forty Year Retrospective -- 14 Pre-CKD? Early markers of renal dysfunction in patients with Prehypertension -- 15 Arterial stiffness in early phases of Prehypertension -- 16 The role of perivascular fat in raising blood pressure in obesity and diabetes -- 17 The Brain -- 18 Diurnal and pulsatile hemodynamics in individuals with PreHypertension -- 19 Systolic hypertension in youth -- 20 Prehypertension and ethnicity: Haemodynamic mechanisms in young adults -- 21 Hemodynamics (systemic and renal) in prehypertension -- 22 Central blood pressure and Prehypertension -- Section 3: Risk assessment in PreHypertension -- 23 Blood pressure measurement, white coat and masked hypertension.-24 Vascular functional and structural risk assessment in prehypertension -- 25 Blood pressure variability -- 26 Morning Surge of Blood Pressure -- 27 Role of ambulatory Blood Pressure Monitoring in Prehypertension -- 28 Home blood pressure, prehypertension and hypertension -- 29 Blood pressure and atherosclerosis- subclinical arteriosclerosis as an early sign of organ damage -- 30 Response to stress, effort and cold pressor test as predictors of Prehypertension -- 31 Physical Activity and Exercise Training as Important Modifiers of Vascular Health -- 32 Prehypertension and associated metabolic risk factors -- IV End organ damage in PreHypertension -- 33 Early cardiovascular dysfunction in Prehypertension -- 34 Effect of blood pressure lowering in hypertensive rats -- V Clinical studies in PreHypertension -- 35 Review of "old and new studies" in the treatment of PreHypertension -- 36 The CHINON study- argument for early treatment of PreHypertension. Effect of age on progression of hypertension -- 37 The PREVER study -- 38 The TROPHY study -- VI Management of PreHypertension -- 39 Non-pharmacologic approaches for the management of prehypertension -- 40 Antihypertensive drugs and vascular health -- 41 Prehypertension: a case in favor of early use of diuretics -- 42 Treatment of High normal blood pressure in the guidelines -- VII Tentative additional chapters -- 43 History of prehypertension: a saga of misunderstanding and neglect -- 44 Management of Prehypertension and hypertension in women of reproductive age.
520 $a This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines. While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions – especially when multiple – are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation. In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases.
650 0 $a Cardiology. $3 593957
650 0 $a Angiology. $3 668966
650 0 $a Diabetes. $3 582755
650 0 $a Metabolic diseases. $3 1253620
650 0 $a Primary care (Medicine). $3 1254357
650 2 4 $a Metabolic Diseases. $3 593967
650 2 4 $a Primary Care Medicine. $3 673694
700 1 $a Zimlichman, Reuven. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1308027
700 1 $a Julius, Stevo. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1308028
700 1 $a Mancia, Giuseppe. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 777973
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319753096
776 0 8 $i Printed edition: $z 9783319753119
830 0 $a Updates in Hypertension and Cardiovascular Protection, $x 2366-4606 $3 1268130
856 4 0 $u https://doi.org/10.1007/978-3-319-75310-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)